clevidipine has been researched along with Myocardial Infarction in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gonon, A; Rydén, L; Segawa, D; Sjöquist, PO; Wang, QD | 1 |
| Grip, L; Månsson, C; Odenstedt, J | 1 |
| Gonon, A; Nordlander, M; Rydén, L; Segawa, D; Sjöquist, PO; Wang, QD | 1 |
3 other study(ies) available for clevidipine and Myocardial Infarction
| Article | Year |
|---|---|
Time-dependent cardioprotection with calcium antagonism and experimental studies with clevidipine in ischemic-reperfused pig hearts: part II.
Topics: Animals; Calcium; Cardiotonic Agents; Coronary Circulation; Female; Hemodynamics; Male; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Pyridines; Swine; Time Factors; Ventricular Fibrillation | 2002 |
Failure to demonstrate myocardial protective effects of the ultra short-acting calcium antagonist clevidipine in a closed-chest reperfusion porcine model.
Topics: Animals; Calcium Channel Blockers; Disease Models, Animal; Female; Hemodynamics; Myocardial Infarction; Myocardial Reperfusion Injury; Pyridines; Swine; Ventricular Fibrillation | 2004 |
Calcium antagonist protects the myocardium from reperfusion injury by interfering with mechanisms directly related to reperfusion: an experimental study with the ultrashort-acting calcium antagonist clevidipine.
Topics: Animals; Calcium; Calcium Channel Blockers; Coronary Circulation; Endothelin-1; Female; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Pyridines; Swine | 2000 |